Repeated cycles of vascular injury by allylamine induce vascular lesions similar to those seen in atherosclerotic vessels, or following balloon catheterization. Vascular (aortic) smooth muscle cells harvested from allylamine-treated animals (i.e., allylamine cells) acquire a proliferative advantage
Collagen suppresses the proliferative phenotype of allylamine-injured vascular smooth muscle cells
β Scribed by Emily Wilson; Alan R. Parrish; Christopher M. Bral; E.Spencer Williams; Kenneth S. Ramos
- Book ID
- 119435500
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 326 KB
- Volume
- 162
- Category
- Article
- ISSN
- 0021-9150
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Abnormal proliferation, migration, and phenotypic modulation of vascular smooth muscle cells (VSMCs) are critical factors in neointima formation during restenosis. The purpose of this study is to determine the efficacy and possible cell signaling mechanisms of apigenin in VSMC activatio
## Abstract Chronic oxidative injury by allylamine (AAM) induces proliferative vascular smooth muscle cell (vSMC) phenotypes in the rat aorta similar to those seen in rodent and human atherosclerotic lesions. The proliferative advantage of AAM vSMC compared to control cells is maintained with seria
## Abstract Restenosis is characterized by vascular smooth muscle cell (VSMC) proliferation and accumulation of collagen III in a hypertrophic and disorganized extracellular matrix. Restenosis is prevented by antimitotic agents or irradiation but no significant progress has been made to control col